Minimally Invasive Robotics - B Shares Rise Over 8%, Full-Year Loss Narrows by 61.1% Year-over-Year

SadMoneyMeow · 2026-03-27T03:09:46+00:00

Minimally Invasive Robot-B Releases 2025 Performance: Revenue of 551 million yuan, up 114.2% year-over-year; Shareholders' net loss of 250 million yuan, narrowed by 61.1% year-over-year. The core product, TuMai Endoscopic Surgery Robot, performed outstandingly, with significant growth in overseas market sales, demonstrating strong global expansion potential.

SadMoneyMeow

2026-03-27 03:09:46

Abstract generation in progress

MicroPort Robotics-B (02252) saw an intraday increase of over 8%. As of the time of writing, the increase has narrowed, with the stock price up 1.91%, at HKD 25.66, with a turnover of HKD 156.8 million.

MicroPort Robotics announced its performance for the year 2025, with revenue of CNY 551 million, a year-on-year increase of 114.2%; the loss attributable to equity shareholders was CNY 250 million, a year-on-year reduction of 61.1%. The company stated that the increase in revenue year-on-year during the period was mainly due to the breakthrough progress in the commercialization of its core product, the TiMAY™ surgical robot, with rapid sales growth, especially significant results in the overseas market expansion of TiMAY, securing over a hundred new overseas market orders throughout the year, and overseas market sales revenue exceeding five times that of last year, with growth rates far exceeding the industry average, demonstrating strong global expansion momentum.

(Author: Dong Pingping)

     【Disclaimer】This article only represents the author's personal views and is unrelated to Hexun. Hexun maintains neutrality regarding the statements and opinions expressed in this article and does not provide any express or implied guarantees regarding the accuracy, reliability, or completeness of the content included. Readers should use it for reference only and assume full responsibility. Email: news_center@staff.hexun.com

Report

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.